JP Morgan Chase’s Agilon Health AGL Stock Holding History

JP Morgan Chase’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,856	Closed	-$957K	–	7395
2024 Q2	$957K	Hold	5,856	–	–	﹤0.01%	4302
2024 Q1	$893K	Hold	5,856	–	–	﹤0.01%	4427
2023 Q4	$1.84M	Buy	+5,856	New	+$2.12M	﹤0.01%	3896
2023 Q2	–	Sell	-10,000	Closed	-$5.94M	–	6883
2023 Q1	$5.94M	Buy	+10,000	New	+$5.6M	﹤0.01%	2690
2022 Q4	–	Sell	-9,900	Closed	-$5.8M	–	6506
2022 Q3	$5.8M	Hold	9,900	–	–	﹤0.01%	2618
2022 Q2	$5.4M	Sell	9,900 -3,164	-24%	-$1.6M	﹤0.01%	2729
2022 Q1	$8.28M	Buy	13,064 +3,900	+43%	+$2.01M	﹤0.01%	2560
2021 Q4	$6.19M	Buy	+9,164	New	+$5.58M	﹤0.01%	2870

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase's AGL Position: Q2 2026 in Review

JP Morgan Chase reduced its Agilon Health (AGL) stake by 48% in Q2 2026, selling an estimated $906K and leaving 14,860 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #4303.

JP Morgan Chase first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.08M in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

JP Morgan Chase held 14,860 shares of Agilon Health worth $1.71M as of Q2 2026.
JP Morgan Chase sold 13,830 Agilon Health shares in Q2 2026, an estimated $906K.
Agilon Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4303 holding.
JP Morgan Chase first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
JP Morgan Chase's Agilon Health position peaked at $7.08M in Q1 2025.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.